OMERS ADMINISTRATION Corp Acquires Shares of 3,120 Astera Labs, Inc. $ALAB

OMERS ADMINISTRATION Corp bought a new position in shares of Astera Labs, Inc. (NASDAQ:ALAB) during the second quarter, HoldingsChannel.com reports. The firm bought 3,120 shares of the company’s stock, valued at approximately $1,507,000.

A number of other institutional investors and hedge funds have also recently made changes to their positions in the business. Vanguard Group Inc. raised its position in shares of Astera Labs by 0.6% in the fourth quarter. Vanguard Group Inc. now owns 13,827,506 shares of the company’s stock valued at $2,300,344,000 after buying an additional 84,365 shares in the last quarter. BlackRock Inc. acquired a new stake in Astera Labs during the second quarter worth approximately $6,609,581,000. Atreides Management LP grew its position in Astera Labs by 108.9% during the first quarter. Atreides Management LP now owns 3,365,787 shares of the company’s stock worth $368,890,000 after buying an additional 1,754,593 shares in the last quarter. State Street Corp increased its stake in Astera Labs by 32.5% during the 4th quarter. State Street Corp now owns 3,099,809 shares of the company’s stock worth $515,684,000 after acquiring an additional 760,358 shares during the period. Finally, Geode Capital Management LLC increased its stake in Astera Labs by 4.5% during the 4th quarter. Geode Capital Management LLC now owns 2,429,078 shares of the company’s stock worth $403,598,000 after acquiring an additional 104,935 shares during the period. Institutional investors and hedge funds own 60.47% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities analysts have weighed in on ALAB shares. Northland Securities raised Astera Labs from a “market perform” rating to an “outperform” rating and set a $350.00 price objective for the company in a report on Monday, August 17th. Bank of America raised their price target on Astera Labs from $240.00 to $450.00 and gave the stock a “neutral” rating in a research report on Tuesday, June 23rd. JPMorgan Chase & Co. boosted their price target on Astera Labs from $205.00 to $280.00 and gave the company an “overweight” rating in a research note on Wednesday, May 6th. Stifel Nicolaus upped their price objective on shares of Astera Labs from $260.00 to $460.00 and gave the stock a “buy” rating in a research report on Wednesday, June 24th. Finally, Roth Capital reaffirmed a “buy” rating and set a $450.00 price objective on shares of Astera Labs in a research report on Wednesday, August 5th. One investment analyst has rated the stock with a Strong Buy rating, fourteen have issued a Buy rating and eight have issued a Hold rating to the stock. According to MarketBeat.com, Astera Labs has an average rating of “Moderate Buy” and a consensus target price of $333.00.

Insiders Place Their Bets

In other Astera Labs news, Director Manuel Alba sold 136,974 shares of the business’s stock in a transaction dated Wednesday, July 1st. The stock was sold at an average price of $442.01, for a total transaction of $60,543,877.74. Following the completion of the transaction, the director owned 1,287,524 shares of the company’s stock, valued at approximately $569,098,483.24. The trade was a 9.62% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Jitendra Mohan sold 90,630 shares of the stock in a transaction dated Monday, August 17th. The stock was sold at an average price of $340.35, for a total transaction of $30,845,920.50. Following the completion of the transaction, the chief executive officer directly owned 1,266,665 shares of the company’s stock, valued at $431,109,432.75. This trade represents a 6.68% decrease in their position. The SEC filing for this sale provides additional information. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders sold a total of 419,244 shares of company stock valued at $163,135,169 over the last ninety days. 10.40% of the stock is owned by insiders.

Astera Labs Price Performance

NASDAQ ALAB opened at $290.30 on Thursday. The business has a fifty day moving average price of $347.19 and a two-hundred day moving average price of $248.42. Astera Labs, Inc. has a fifty-two week low of $97.89 and a fifty-two week high of $499.48. The stock has a market capitalization of $50.36 billion, a PE ratio of 143.71 and a beta of 3.84.

Astera Labs (NASDAQ:ALAB) last issued its earnings results on Tuesday, August 4th. The company reported $0.80 earnings per share for the quarter, beating analysts’ consensus estimates of $0.69 by $0.11. Astera Labs had a return on equity of 19.24% and a net margin of 30.74%.The firm had revenue of $392.40 million for the quarter, compared to the consensus estimate of $360.85 million. During the same quarter last year, the business posted $0.44 EPS. The company’s revenue was up 104.5% compared to the same quarter last year. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. As a group, sell-side analysts expect that Astera Labs, Inc. will post 2.7 earnings per share for the current year.

Astera Labs Company Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.